A whole cell pathway screen reveals seven novel chemosensitizers to combat chloroquine resistant malaria
<br xmlns:etd="http://www.ouls.ox.ac.uk/ora/modsextensions">Due to the widespread prevalence of resistant parasites, chloroquine (CQ) was removed from front-line antimalarial chemotherapy in the 1990s despite its initial promise of disease eradication. Since then, resistance-conferri...
Main Authors: | Ch'Ng, J, Mok, S, Bozdech, Z, Lear, M, Boudhar, A, Russell, B, Nosten, F, Tan, K |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado: |
Springer Nature
2013
|
Títulos similares
-
A whole cell pathway screen reveals seven novel chemosensitizers to combat chloroquine resistant malaria
por: Ch'ng, Jun-Hong, et al.
Publicado: (2013) -
Overcoming chloroquine resistance in malaria: Design, synthesis and structure-activity relationships of novel chemoreversal agents.
por: Boudhar, A, et al.
Publicado: (2016) -
Validation of a chloroquine-induced cell death mechanism for clinical use against malaria.
por: Ch'ng, J, et al.
Publicado: (2014) -
Comparison of artemether and chloroquine for severe malaria in Gambian children.
por: White, N, et al.
Publicado: (1992) -
Comparison of the umulative efficacy and safety of chloroquine, artesunate, and chloroquine-primaquine in
Plasmodium vivax malaria
por: Chu, C, et al.
Publicado: (2018)